MYGN

#3012
Myriad Genetics Inc
4.8250 USD
+5.12%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
4.7850
4.8300
1年のレンジ
4.1050
8.5000
1日の変化
+5.12%
月次変化
+3.54%
6か月変化
-41.66%
1年の変化
-41.66%
以前の終値
4.5900
始値
4.8000
Bid
Ask
安値
4.7850
High
4.8300
ボリューム
160
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 451.1769 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.56
売上高対価格比率
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

ニュース